Innovative Strategies and Challenges in Breast Cancer Therapy: Advances in Raloxifene, Curcumin, and Nanostructured Lipid Carriers
DOI:
https://doi.org/10.54536/ajmhc.v1i2.7836Keywords:
Breast Cancer, Curcumin, Nanostructured Lipid Carriers, Narrative Review, Raloxifene, Targeted Drug Delivery, Triple-Negative Breast CancerAbstract
In this narrative review, the authors discuss the emerging therapeutic applications of breast cancer with an emphasis on synergetic potential of raloxifene and curcumin, and use of nanostructured lipid carriers (NLCs) as novel drug delivery systems. Raloxifene with selective estrogen receptor modulator (SERM) activity and curcumin with polyphenolic compounds with anti-inflammatory, antioxidant, and anticancer effects possess good effectiveness in the case of hormone-sensitive breast cancer. They are however limited in their clinical application by low bioavailability, quick degradation and low absorption. NLCs used in combination of solid and liquid lipids provide an effective alternative since they stabilize the drugs as well as have the advantage of increasing absorption and specific tumor targeting. These carriers facilitate co-delivery of raloxifene and curcumin at low dose exposure and an increased therapeutic effect and reduced systemic toxicity. Using literature, this review also looks at breast cancer subtypes, their molecular characteristics and the inadequacy of the standard management like chemotherapy, radiotherapy and endocrine therapy. It covers the new focused treatment modality, e.g., PI3K/AKT/mTOR inhibitors, selective estrogen receptor degraders (SERDs), anti-HER2 therapies, and PARPI, particularly to aggressive forms of triple-negative breast cancer (TNBC). These approaches reveal the significance of individualized approaches of treatment with the inclusion of nanomedicine. In summation, this narrative review identifies the therapeutic potential of molecular targeting in combination with lipid-based nanocarriers to overcome the issue of resistance and enhance breast cancer treatments.
Downloads
References
Abasher, M. M., Sidahmed, A. A., Abdelmoniem, A., & Ahmed, H. O. M. (2023). Breast Cancer in Elderly Females. American Journal of Medical Science and Innovation, 2(2), 16-25. https://doi.org/10.54536/ajmsi.v2i2.1711
Al-Hilli, Z., & Wilkerson, A. (2021). Breast Surgery: Management of Postoperative Complications Following Operations for Breast Cancer. The Surgical clinics of North America, 101(5), 845–863. https://doi.org/10.1016/j.suc.2021.06.014
Amir, E., Freedman, O. C., Seruga, B., & Evans, D. G. (2010). Assessing women at high risk of breast cancer: a review of risk assessment models. Journal of the National Cancer Institute, 102(10), 680–691. https://doi.org/10.1093/jnci/djq088
Andre, F., Ismaila, N., Allison, K. H., Barlow, W. E., Collyar, D. E., Damodaran, S., Henry, N. L., Jhaveri, K., Kalinsky, K., Kuderer, N. M., Litvak, A., Mayer, E. L., Pusztai, L., Raab, R., Wolff, A. C., & Stearns, V. (2022). Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(16), 1816–1837. https://doi.org/10.1200/JCO.22.00069
Azamjah, N., Soltan-Zadeh, Y., & Zayeri, F. (2019). Global Trend of Breast Cancer Mortality Rate: A 25-Year Study. Asian Pacific journal of cancer prevention : APJCP, 20(7), 2015–2020. https://doi.org/10.31557/APJCP.2019.20.7.2015
Baines C. J. (1992). Physical examination of the breasts in screening for breast cancer. Journal of gerontology, 47 Spec No, 63–67.
Bartelink, H., Horiot, J.-C., Poortmans, P. M., Struikmans, H., Van den Bogaert, W., Fourquet, A., Jager, J. J., Hoogenraad, W. J., Oei, S. B., Wárlám-Rodenhuis, C. C., Pierart, M., & Collette, L. (2007). Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. Journal of Clinical Oncology, 25(22), 3259–3265. https://doi.org/10.1200/JCO.2007.11.4991
Bhuiyan, M. R. H., Mamun, A. A., Sharker, B., & Jaman, M. S. (2023). Anticancer activity and therapeutic uses of catechins on breast, prostate and lung cancer: Future perspective and clinical proofs. Journal of Clinical Case Reports, Medical Images and Health Sciences, 3(3). https://doi.org/10.55920/JCRMHS.2023.03.001118
Bhuiyan, M. R. H., Maniruzzaman, M., Akter, S., Rashid, M. H. B., Ehasanullah, M., & Jaman, M. S. (2022). Assessment of antioxidant and antineoplastic activities of Blumea lacera (Burn. f.) leaves. International Academic Journal of Applied Bio-Medical Sciences, 3(2). https://doi.org/10.47310/iajabms.2022.v03i02.001
Bonfill, X., Marzo, M., Pladevall, M., Martí, J., & Emparanza, J. I. (2001). Strategies for increasing women participation in community breast cancer screening. The Cochrane database of systematic reviews, 2001(1), CD002943. https://doi.org/10.1002/14651858.CD002943
Carbine, N. E., Lostumbo, L., Wallace, J., & Ko, H. (2018). Risk-reducing mastectomy for the prevention of primary breast cancer. The Cochrane database of systematic reviews, 4(4), CD002748. https://doi.org/10.1002/14651858.CD002748.pub4
Cserni G. (2020). Histological type and typing of breast carcinomas and the WHO classification changes over time. Pathologica, 112(1), 25–41. https://doi.org/10.32074/1591-951X-1-20
Davis-Turak, J., Courtney, S. M., Hazard, E. S., Glen, W. B., Jr, da Silveira, W. A., Wesselman, T., Harbin, L. P., Wolf, B. J., Chung, D., & Hardiman, G. (2017). Genomics pipelines and data integration: challenges and opportunities in the research setting. Expert review of molecular diagnostics, 17(3), 225–237. https://doi.org/10.1080/14737159.2017.1282822
Debien, V., De Caluwé, A., Wang, X., Piccart-Gebhart, M., Tuohy, V. K., Romano, E., & Buisseret, L. (2023). Immunotherapy in breast cancer: an overview of current strategies and perspectives. NPJ breast cancer, 9(1), 7. https://doi.org/10.1038/s41523-023-00508-3
Dieci, M. V., Vernaci, G., & Guarneri, V. (2019). Escalation and de-escalation in HER2 positive early breast cancer. Current opinion in oncology, 31(1), 35–42. https://doi.org/10.1097/CCO.0000000000000492
Doren, A., Vecchiola, A., Aguirre, B., & Villaseca, P. (2018). Gynecological-endocrinological aspects in women carriers of BRCA1/2 gene mutations. Climacteric : the journal of the International Menopause Society, 21(6), 529–535. https://doi.org/10.1080/13697137.2018.1514006
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., Elias, A. D., Giordano, S. H., Goetz, M. P., Goldstein, L. J., Hurvitz, S. A., Isakoff, S. J., Jankowitz, R. C., Javid, S. H., Krishnamurthy, J., Leitch, M., … Kumar, R. (2022). Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 20(6), 691–722. https://doi.org/10.6004/jnccn.2022.0030
Gucalp, A., Traina, T. A., Eisner, J. R., Parker, J. S., Selitsky, S. R., Park, B. H., Elias, A. D., Baskin-Bey, E. S., & Cardoso, F. (2019). Male breast cancer: a disease distinct from female breast cancer. Breast cancer research and treatment, 173(1), 37–48. https://doi.org/10.1007/s10549-018-4921-9
Husinka, L., Koerner, P. H., Miller, R. T., & Trombatt, W. (2020). Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer. Journal of drug assessment, 10(1), 27–34. https://doi.org/10.1080/21556660.2020.1857103
Jaman MS, Bhuiyan MRH, Maniruzzaman M, et al., (2023) Preventive and therapeutic effect of ellagic acid, sulforphane and ursolic acid on colon cacner: from cellular response to molecular mechanism of action with future perspectives. Int J Clin Med Case Rep.;30
Jaman, M. S. (2025). A review potential radioprotective mechanism of molecular hydrogen via regulation of cellular signaling pathways. Radinka Journal of Health Science, 3(2), 503–528. https://doi.org/10.56778/rjhs.v3i2.591
Jaman, M. S. ., Bhuiyan, M. R. H., Maniruzzaman, M., Tasnova, M., Monira, S. ., Rana, M. R. R. ., … Arif, S. I. . (2025). Natural Radioprotectors For Oncology: Therapeutic and Diagnostic Prospects. Journal of Healthcare and Biomedical Science , 4(1), 14–42. https://doi.org/10.31098/jhbs.v4i1.3867
Jaman, M. S., & Sayeed, M. A. (2018). Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives. Breast cancer (Tokyo, Japan), 25(5), 517–528. https://doi.org/10.1007/s12282-018-0866-4
Jaman, M. S., Al Mamun, A., Sharker, B., Maniruzzaman, M., Rana, M. R. R., Hasan, M. N., & Bhuiyan, M. R. H. (2023). Curcumin, diallyl sulphide, quercetin and gallic acid uses as anticancer and therapeutic agents for breast cancer: Current strategies and future perspectives. European Journal of Medical and Health Sciences, 5(3), 32–48. https://doi.org/10.24018/ejmed.2023.5.3.1699
Jaman, M. S., Alam, S., Rezwan, S., Islam, R., Husna, A. U., & Sayeed, M. A. (2017). Association of mean platelet volume and platelet distribution width with HbA1c. Journal of Endocrinology and Diabetes, 4(4), 1–6. https://doi.org/10.15226/2374-6890/4/4/00183
Jaman, M. S., Maniruzzaman, M., Rana, M. R. R., Bhuiyan, M. R. H., Akter, L., Ahmad, S., Ullah, M. N., & Saifujjaman, M. (2024). Overall summery of Gulf country employees from Bangladesh, preliminary evaluation for abnormal kidney liver and virally infected individuals using low-cost tests like CBC parameters. Chemical Science International Journal, 33(4), 19–33. https://doi.org/10.9734/CSJI/2024/v33i4903
Jaman, M. S., Rahman, M. S., Swarna, R. R., Mahato, J., Miah, M. M., & Ayshasiddeka, M. (2018). Diabetes and red blood cell parameters. Annals of Clinical Endocrinology and Metabolism, 2(1), 001–009. https://doi.org/10.29328/journal.acem.1001004
Jaman, Md. Sadikuj, Maniruzzaman, Md., Bhuiyan, Md. Rokibul Hasan, Haque, Md Shajedul, (2026) The Roles of MicroRNAs, Oncogenes, and Tumor Suppressor Gene Molecular Subtypes of Breast Cancer: Therapeutic Potential of Pharmaceutical and Natural Products, International Journal of Breast Cancer, 2576658, 40 pages, 2026. https://doi.org/10.1155/ijbc/2576658
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022). Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. BioMed research international, 2022, 9605439. https://doi.org/10.1155/2022/9605439
Kerlikowske, K., Grady, D., Barclay, J., Frankel, S. D., Ominsky, S. H., Sickles, E. A., & Ernster, V. (1998). Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. Journal of the National Cancer Institute, 90(23), 1801–1809. https://doi.org/10.1093/jnci/90.23.1801
Kirby A. M. (2018). Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial?. The British journal of radiology, 91(1085), 20170565. https://doi.org/10.1259/bjr.20170565
Korde, L. A., Somerfield, M. R., Carey, L. A., Crews, J. R., Denduluri, N., Hwang, E. S., Khan, S. A., Loibl, S., Morris, E. A., Perez, A., Regan, M. M., Spears, P. A., Sudheendra, P. K., Symmans, W. F., Yung, R. L., Harvey, B. E., & Hershman, D. L. (2021). Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(13), 1485–1505. https://doi.org/10.1200/JCO.20.03399
Maniruzzaman, M., Bhuiyan, M. R. H., Jaman, M. S., & Haque, M. S. (2025). MicroRNA dynamics, PTEN/PI3K/AKT signaling, and their relationship to breast cancer: prospects for pharmaceuticals and natural product application. Breast cancer research and treatment, 209(3), 467–485. https://doi.org/10.1007/s10549-024-07600-7:1-31.
Maniruzzaman, M., Deb Nath, S., Ray Sobuj, D., et al., (2025) Ayurvedic medicine: A complementary path in modern sports medicine. Eksplorium-Buletin Pusat Teknologi Bahan Galian Nuklir, 46(02). https://doi.org/10.52783/eksplorium.267
Maniruzzaman, M., Hasan, M. N., Tasnim, N., Hasan, M. I., Hasan Babu, S. M., Murshed, M. Y., et al., (2025). Role of diet, exercise, and aging process on the human immune system. Journal of Medical & Health Sciences Review, 2(1). https://doi.org/10.62019/nt28dv52
Maniruzzaman, M., Rana, M. R. R., Mizan, M., Hasan, M. S., Nasim, M., Islam, S., Mony, J. F. E., Shimo, F. A., Tasnim, M. N., & Hasan, M. N. (2025). The evolving role of hospital and community pharmacist in post-COVID-19 healthcare delivery in Bangladesh: A survey-based analysis. Journal of Angiotherapy, 9(1), 1–9. https://doi.org/10.25163/angiotherapy.9110227
Mann, R. M., Kuhl, C. K., & Moy, L. (2019). Contrast-enhanced MRI for breast cancer screening. Journal of magnetic resonance imaging : JMRI, 50(2), 377–390. https://doi.org/10.1002/jmri.26654
McCart Reed, A. E., Kalinowski, L., Simpson, P. T., & Lakhani, S. R. (2021). Invasive lobular carcinoma of the breast: the increasing importance of this special subtype. Breast cancer research : BCR, 23(1), 6. https://doi.org/10.1186/s13058-020-01384-6
McDonald, S., Saslow, D., & Alciati, M. H. (2004). Performance and reporting of clinical breast examination: a review of the literature. CA: a cancer journal for clinicians, 54(6), 345–361. https://doi.org/10.3322/canjclin.54.6.345
Menta, A., Fouad, T. M., Lucci, A., Le-Petross, H., Stauder, M. C., Woodward, W. A., Ueno, N. T., & Lim, B. (2018). Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer. The Surgical clinics of North America, 98(4), 787–800. https://doi.org/10.1016/j.suc.2018.03.009
Nielsen, S., & Narayan, A. K. (2023). Breast Cancer Screening Modalities, Recommendations, and Novel Imaging Techniques. The Surgical clinics of North America, 103(1), 63–82. https://doi.org/10.1016/j.suc.2022.08.004
Overgaard, M., Nielsen, H. M., Tramm, T., Højris, I., Grantzau, T. L., Alsner, J., Offersen, B. V., Overgaard, J., & DBCG Radiotherapy Group (2022). Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 170, 4–13. https://doi.org/10.1016/j.radonc.2022.03.008
Parada, H., Jr, Sun, X., Tse, C. K., Olshan, A. F., & Troester, M. A. (2019). Lifestyle Patterns and Survival Following Breast Cancer in the Carolina Breast Cancer Study. Epidemiology (Cambridge, Mass.), 30(1), 83–92. https://doi.org/10.1097/EDE.0000000000000933
Pediconi, F., Marzocca, F., Cavallo Marincola, B., & Napoli, A. (2018). MRI-guided treatment in the breast. Journal of magnetic resonance imaging : JMRI, 48(6), 1479–1488. https://doi.org/10.1002/jmri.26282
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lønning, P. E., Børresen-Dale, A. L., Brown, P. O., & Botstein, D. (2000). Molecular portraits of human breast tumours. Nature, 406(6797), 747–752. https://doi.org/10.1038/35021093
Prat, A., Pineda, E., Adamo, B., Galván, P., Fernández, A., Gaba, L., Díez, M., Viladot, M., Arance, A., & Muñoz, M. (2015). Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast (Edinburgh, Scotland), 24 Suppl 2, S26–S35. https://doi.org/10.1016/j.breast.2015.07.008
Radovic, N., Ivanac, G., Divjak, E., Biondic, I., Bulum, A., & Brkljacic, B. (2019). Evaluation of Breast Cancer Morphology Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI: Intermethod and Interobserver Agreement. Journal of magnetic resonance imaging : JMRI, 49(5), 1381–1390. https://doi.org/10.1002/jmri.26332
Rana, M. R. R., Maniruzzaman, M., Ali, M. S., Hossen, M. M., Hasan, M. N., Rony, M. H. R., Siam, S. M., Atik, M. S., Alam, J., Hridoy, M. S. R., Chowdhury, K. A., & Shohag, A. M. (2024). Systematic review on current managements of irritable bowel syndrome by complementary and alternative medicine. American Journal of Medical Science and Innovation, 3(2), 109–120. https://doi.org/10.54536/ajmsi.v3i2.3427
Roulot, A., Héquet, D., Guinebretière, J. M., Vincent-Salomon, A., Lerebours, F., Dubot, C., & Rouzier, R. (2016). Tumoral heterogeneity of breast cancer. Hétérogénéité tumorale des cancers du sein. Annales de biologie clinique, 74(6), 653–660. https://doi.org/10.1684/abc.2016.1192
Roux, P., Knight, S., Cohen, M., Classe, J. M., Mazouni, C., Chauvet, M. P., Reyal, F., Colombo, P. E., Jouve, E., Chopin, N., Daraï, E., Coutant, C., Lambaudie, E., & Houvenaeghel, G. (2019). Tubular and mucinous breast cancer: results of a cohort of 917 patients. Tumori, 105(1), 55–62. https://doi.org/10.1177/0300891618811282
Shien, T., & Iwata, H. (2020). Adjuvant and neoadjuvant therapy for breast cancer. Japanese journal of clinical oncology, 50(3), 225–229. https://doi.org/10.1093/jjco/hyz213
Shinnwai, A. E. (2024). Systematic Review and Meta-Analysis of Surgical Versus Non-Surgical Management for Varicocele: Comparative Evaluation of Fertility Outcomes and Complication Rates. American Journal of Medical Science and Innovation, 3(2), 121-130. https://doi.org/10.54536/ajmsi.v3i2.3694
Sobuj, D. R., Bhuiyan, M. R. H., Rashid, T., Arif, S. I., Rana, M. R. R., Maniruzzaman, M., Akter, S., & Jaman, M. S. (2025). Intermittent fasting as a lifestyle strategy for diabetes and heart health in the United States: A systematic review. Clinical Epidemiology & Public Health, 3(11), 1–8. https://doi.org/10.25163/health.3110408
Sobuj, D. R., Bhuiyan, M. R. H., Rashid, T., Arif, S. I., Rana, M. R. R., Maniruzzaman, M., Akter, S., & Jaman, M. S. (2025). Breast cancer in the United States: current treatment and diagnosis strategies, risk factors and preventive methods. International Journal Of Community Medicine And Public Health, 12(12), 5839–5843. https://doi.org/10.18203/2394-6040.ijcmph20254069
Song, D., Zhang, H., Ren, C., Zhan, N., Xie, L., & Xie, W. (2024). Accelerated partial breast irradiation: Current evidence and future developments. Cancer innovation, 3(1), e106. https://doi.org/10.1002/cai2.106
Sun, Y. S., Zhao, Z., Yang, Z. N., Xu, F., Lu, H. J., Zhu, Z. Y., Shi, W., Jiang, J., Yao, P. P., & Zhu, H. P. (2017). Risk Factors and Preventions of Breast Cancer. International journal of biological sciences, 13(11), 1387–1397. https://doi.org/10.7150/ijbs.21635
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Tang, L., Matsushita, H., & Jingu, K. (2018). Controversial issues in radiotherapy after breast-conserving surgery for early breast cancer in older patients: a systematic review. Journal of radiation research, 59(6), 789–793. https://doi.org/10.1093/jrr/rry071
Wang, L., Guyatt, G. H., Kennedy, S. A., Romerosa, B., Kwon, H. Y., Kaushal, A., Chang, Y., Craigie, S., de Almeida, C. P. B., Couban, R. J., Parascandalo, S. R., Izhar, Z., Reid, S., Khan, J. S., McGillion, M., & Busse, J. W. (2016). Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne, 188(14), E352–E361. https://doi.org/10.1503/cmaj.151276
Wang, X., Xu, L., Yin, Z., Wang, D., Wang, Q., Xu, K., Zhao, J., Zhao, L., Yuan, Z., & Wang, P. (2018). Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy. Cancer management and research, 10, 4105–4112. https://doi.org/10.2147/CMAR.S173628
Whelan, T. J., Olivotto, I. A., Parulekar, W. R., Ackerman, I., Chua, B. H., Nabid, A., Vallis, K. A., White, J. R., Rousseau, P., Fortin, A., Pierce, L. J., Manchul, L., Chafe, S., Nolan, M. C., Craighead, P., Bowen, J., McCready, D. R., Pritchard, K. I., Gelmon, K., Murray, Y., … MA.20 Study Investigators (2015). Regional Nodal Irradiation in Early-Stage Breast Cancer. The New England journal of medicine, 373(4), 307–316. https://doi.org/10.1056/NEJMoa1415340
Wu, Y. T., Xu, Z., Zhang, K., Wu, J. S., Li, X., Arshad, B., Li, Y. C., Wang, Z. L., Li, H. Y., Wu, K. N., & Kong, L. Q. (2018). Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis. Therapeutics and clinical risk management, 14, 1789–1797. https://doi.org/10.2147/TCRM.S176214
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z. S., Kumar, A., Vishakha, Behl, T., Jha, S. K., & Tang, H. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular cancer, 22(1), 105. https://doi.org/10.1186/s12943-023-01805-y
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mst. Tasnova, Israt Jahan Tamanna, Md. Abid Hossain, Md. Maniruzzaman, Md Mahfuz Miah, Md.Rakib Rased Rana, Md Sadikuj Jaman (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
